UpcomingIPO
Actions
Middle East Pharmaceutical Industries Company
Pharma, Biotech and Life Sciences
Prospectus
DownloadCompany Contact Details
P.O. Box
Second Industrial City, Riyadh
P.O. Box 3800 Riyadh 14331
Kingdom of Saudi Arabia
Phone
00966112653948
FAX
00966112654723
Website
www.avalonpharmaceutical.com
Company Main Activities
The Company’s activity, according to its commercial registration, is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use. The Company’s objectives, according to its bylaws, are as follows: Transformative Industries, Transportation and storage, Wholesale and retail trade and repair of motor vehicles and motorcycles for more information, please refer to company’s prospectus.
| Summary | |
|---|---|
| Authorized Capital | 200,000,000 SAR |
| Issue Type | Equity |
| Total Issue Shares | 20,000,000 |
| Issue Price | 82 |
| Shares Offering Size | 6,000,000 |
| Percentage of Shares offering size to be total issue shares | 30% |
| Issue Manager | Alinma Investment Company |
| Main Underwriter | Alinma Investment Company |
| Important Dates | |
|---|---|
| Financial Year End | 12-31 |
| Offering Date | 2024/01/30 |
| Closing Date | 2024/02/01 |
| Receiving Entities |
|---|
| Alinma Bank, Saudi National Bank. |